164 related articles for article (PubMed ID: 37978232)
1. Calcium channel blockers may reduce the development of long COVID in females.
Ozawa T; Kimura R; Terai H; Takemura R; Namkoong H; Kondo M; Fukuda K; Yagi K; Asakura T; Masaki K; Chubachi S; Miyata J; Ohgino K; Kawada I; Kagyo J; Odani T; Kuwahara N; Nakachi I; Ishii M; Sato Y; Fukunaga K
Hypertens Res; 2024 Apr; 47(4):934-943. PubMed ID: 37978232
[TBL] [Abstract][Full Text] [Related]
2. Outcomes of Hospitalized COVID-19 Patients Receiving Renin Angiotensin System Blockers and Calcium Channel Blockers.
Choksi TT; Zhang H; Chen T; Malhotra N
Am J Nephrol; 2021; 52(3):250-260. PubMed ID: 33827074
[TBL] [Abstract][Full Text] [Related]
3. Angiotensin-Converting Enzyme Inhibitors or Angiotensin Receptor Blockers Use and COVID-19 Infection Among 824 650 Patients With Hypertension From a US Integrated Healthcare System.
An J; Wei R; Zhou H; Luong TQ; Gould MK; Mefford MT; Harrison TN; Creekmur B; Lee MS; Sim JJ; Brettler JW; Martin JP; Ong-Su AL; Reynolds K
J Am Heart Assoc; 2021 Feb; 10(3):e019669. PubMed ID: 33307964
[TBL] [Abstract][Full Text] [Related]
4. Effects of Long- and Intermediate-Acting Dihydropyridine Calcium Channel Blockers in Hypertension: A Systematic Review and Meta-Analysis of 18 Prospective, Randomized, Actively Controlled Trials.
Chaugai S; Sherpa LY; Sepehry AA; Kerman SRJ; Arima H
J Cardiovasc Pharmacol Ther; 2018 Sep; 23(5):433-445. PubMed ID: 29739234
[TBL] [Abstract][Full Text] [Related]
5. Compliance of Antihypertensive Medication and Risk of Coronavirus Disease 2019: a Cohort Study Using Big Data from the Korean National Health Insurance Service.
Kim J; Kim DW; Kim KI; Kim HB; Kim JH; Lee YG; Byeon KH; Cheong HK;
J Korean Med Sci; 2020 Jun; 35(25):e232. PubMed ID: 32597045
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological interventions for hypertension in children.
Chaturvedi S; Lipszyc DH; Licht C; Craig JC; Parekh R
Evid Based Child Health; 2014 Sep; 9(3):498-580. PubMed ID: 25236305
[TBL] [Abstract][Full Text] [Related]
7. Calcium channel blockers improve prognosis of patients with coronavirus disease 2019 and hypertension.
Peng C; Wang H; Guo YF; Qi GY; Zhang CX; Chen T; He J; Jin ZC
Chin Med J (Engl); 2021 Jun; 134(13):1602-1609. PubMed ID: 34133354
[TBL] [Abstract][Full Text] [Related]
8. Association between cardiovascular outcomes and antihypertensive drug treatment in older women.
Wassertheil-Smoller S; Psaty B; Greenland P; Oberman A; Kotchen T; Mouton C; Black H; Aragaki A; Trevisan M
JAMA; 2004 Dec; 292(23):2849-59. PubMed ID: 15598916
[TBL] [Abstract][Full Text] [Related]
9. Effect of Antihypertensive Medications on Sepsis-Related Outcomes: A Population-Based Cohort Study.
Kim J; Kim YA; Hwangbo B; Kim MJ; Cho H; Hwangbo Y; Lee ES
Crit Care Med; 2019 May; 47(5):e386-e393. PubMed ID: 30688717
[TBL] [Abstract][Full Text] [Related]
10. Antihypertensive Drugs and COVID-19 Risk: A Cohort Study of 2 Million Hypertensive Patients.
Semenzato L; Botton J; Drouin J; Baricault B; Vabre C; Cuenot F; Penso L; Herlemont P; Sbidian E; Weill A; Dray-Spira R; Zureik M
Hypertension; 2021 Mar; 77(3):833-842. PubMed ID: 33423528
[TBL] [Abstract][Full Text] [Related]
11. Cochrane in context: pharmacological interventions for hypertension in children.
Chaturvedi S; Lipszyc DH; Licht C; Craig JC; Parekh RS
Evid Based Child Health; 2014 Sep; 9(3):581-3. PubMed ID: 25236306
[TBL] [Abstract][Full Text] [Related]
12. Lack of association of antihypertensive drugs with the risk and severity of COVID-19: A meta-analysis.
Ren L; Yu S; Xu W; Overton JL; Chiamvimonvat N; Thai PN
J Cardiol; 2021 May; 77(5):482-491. PubMed ID: 33168337
[TBL] [Abstract][Full Text] [Related]
13. Antihypertensive drug therapy for mild to moderate hypertension during pregnancy.
Abalos E; Duley L; Steyn DW; Gialdini C
Cochrane Database Syst Rev; 2018 Oct; 10(10):CD002252. PubMed ID: 30277556
[TBL] [Abstract][Full Text] [Related]
14. Using medication history to measure confounding by indication in assessing calcium channel blockers and other antihypertensive therapy.
Leader S; Mallick R; Roht L
J Hum Hypertens; 2001 Mar; 15(3):153-9. PubMed ID: 11317198
[TBL] [Abstract][Full Text] [Related]
15. Impact of antihypertensive agents on clinical course and in-hospital mortality: analysis of 169 hypertensive patients hospitalized for COVID-19.
Kocayigit I; Kocayigit H; Yaylaci S; Can Y; Erdem AF; Karabay O
Rev Assoc Med Bras (1992); 2020; 66Suppl 2(Suppl 2):71-76. PubMed ID: 32965360
[TBL] [Abstract][Full Text] [Related]
16. Incidence and Mortality Associated with Cardiovascular Medication among Hypertensive COVID-19 Patients in South Korea.
Oh TK; Cho HW; Suh JW; Song IA
Yonsei Med J; 2021 Jul; 62(7):577-583. PubMed ID: 34164954
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic target and clinical impact of day-to-day blood pressure variability in hypertensive patients with covid-19.
Jagannatha GNP; Yasmin AAADA; Pradnyana IWAS; Kamardi S; Pradnyaandara IGBMA; Pangkahila EE; Perkasa GOBD; Wibawa IBS
Hypertens Res; 2023 Jan; 46(1):165-174. PubMed ID: 36280737
[TBL] [Abstract][Full Text] [Related]
18. Association of Antihypertensive Agents with the Risk of In-Hospital Death in Patients with Covid-19.
Chouchana L; Beeker N; Garcelon N; Rance B; Paris N; Salamanca E; Polard E; Burgun A; Treluyer JM; Neuraz A;
Cardiovasc Drugs Ther; 2022 Jun; 36(3):483-488. PubMed ID: 33595761
[TBL] [Abstract][Full Text] [Related]
19. First-line diuretics versus other classes of antihypertensive drugs for hypertension.
Reinhart M; Puil L; Salzwedel DM; Wright JM
Cochrane Database Syst Rev; 2023 Jul; 7(7):CD008161. PubMed ID: 37439548
[TBL] [Abstract][Full Text] [Related]
20. First-line drugs for hypertension.
Wright JM; Musini VM; Gill R
Cochrane Database Syst Rev; 2018 Apr; 4(4):CD001841. PubMed ID: 29667175
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
